Clinical Trial Update: Oral Selenium Therapy for the Prevention of Mucositis [Phase 1, Phase 2]

View source ↗

Summary

Updates on a Phase 1/2 clinical trial evaluating oral selenium to prevent mucositis in hematopoietic stem cell transplant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucositis

Drugs mentioned

• Selenium (selenium)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Mucositis, Hematopoietic Stem Cell Transplantation | Phase 1, Phase 2 | Status: UNKNOWN